Arsenic inhibits the adipogenic differentiation of mesenchymal stem cells by down-regulating peroxisome proliferator-activated receptor gamma and CCAAT enhancer-binding proteins

Toxicology in Vitro

Volumn 27, Issue 1, 2013, Pages 211-219

  Yadav, Santosh ^a   Anbalagan, Muralidharan ^a   Shi, Yongli ^b   Wang, Feng ^c   Wang, He ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adipogenesis; Arsenic; C EBP family proteins; Differentiation; Mesenchymal stem cells; PPAR

Indexed keywords

2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; ADIPOCYTE FATTY ACID BINDING PROTEIN AP2; ARSENIC; CCAAT ENHANCER BINDING PROTEIN; FAT DROPLET; FATTY ACID BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADULT; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ARSENIC; BENZAMIDES; CARCINOGENS; CCAAT-ENHANCER-BINDING PROTEINS; CELL SURVIVAL; CELLS, CULTURED; CHROMANS; ENVIRONMENTAL POLLUTANTS; FATTY ACID-BINDING PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; PPAR GAMMA; PYRIDINES; THIAZOLIDINEDIONES; WNT SIGNALING PATHWAY;

EID: 84869436740     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.10.012     Document Type: Article

References (56)

1. Baron R., Rawadi G., Roman-Roman S. Wnt signaling: a key regulator of bone mass. Curr. Top. Dev. Biol. 2006, 76:103-127.
2. Bezy O., Vernochet C., Gesta S., Farmer S.R., Kahn C.R. TRB3 blocks adipocyte differentiation through the inhibition of C/EBPbeta transcriptional activity. Mol. Cell. Biol. 2007, 27(19):6818-6831.
3. Christy R.J., Yang V.W., Ntambi J.M., Geiman D.E., Landschulz W.H., Lane M.D. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. 1991, 88:2593-2597.
4. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20(5):649-688.
5. Engela A.U., Baan C.C., Peeters A.M., Weimar W., Hoogduijn M.J. Interaction between adipose-tissue derived mesenchymal stem cells and regulatory T cells. Cell Transplant. 2010, (Epub ahead of print).
6. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 2006, 4(4):263-273.
7. Feussner J.R., Shelburne J.D., Bredehoeft S., Cohen H.J. Arsenic-induced bone marrow toxicity: ultrastructural and electron-probe analysis. Blood 1979, 53(5):820-827.
8. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., Panasuk A.F., Rudakowa S.F., Luria E.A., et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol. 1974, 2(2):83-92.
9. Hester S., Drobna Z., Andrews D., Liu J., Waalkes M., Thomas D., et al. Expression of AS3MT alters transcriptional profiles in human urothelial cells exposed to arsenite. Hum. Exp. Toxicol. 2009, 28(1):49-61.
10. Hu E., Tontonoz P., Spiegelman B.M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR∼/and C/EBP∼. Proc. Natl. Acad. Sci. 1995, 92:9856-9860.
11. IARC, 1987. Overall evaluations of carcinogenicity: an updating of IARC monographs. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 1-42 (suppl 7).
12. Kachinskas D.J., Phillips M.A., Qin Q., Stokes J.D., Rice R.H. Arsenate perturbation of human keratinocyte differentiation. Cell Growth Differ. 1994, 5(11):1235-1241.
13. Kennell J.A., MacDougald O.A. Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. J. Biol. Chem. 2005, 280(25):24004-24010.
14. Krause U., Harris S., Green A., Ylostalo J., Zeitouni S., Lee N., et al. Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(9):4147-4152.
15. Krishnan V., Bryant H.U., Macdougald O.A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 2006, 116(5):1202-1209.
16. Kumar A., Adak P., Gurian P.L., Lockwood J.R. Arsenic exposure in US public and domestic drinking water supplies: a comparative risk assessment. J. Expo. Sci. Environ. Epidemiol. 2010, 20(3):245-254.
17. Lee H., Bae S., Kim K., Kim W., Chung S.I., Yoon Y. Beta-catenin mediates the anti-adipogenic effect of baicalin. Biochem. Biophys. Res. Commun. 2010, 398(4):741-746.
18. Li W., Ren G., Huang Y., Su J., Han Y., Li J., Chen X., Cao K., Chen Q., Shou P., Zhang L., Yuan Z.R., Roberts A.I., Shi S., Le A.D., Shi Y. Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ. 2012, 10.1038/cdd.2012.26.
19. Lim S., Jang H.J., Kim J.K., Kim J.M., Park E.H., Yang J.H., et al. Ochratoxin A Inhibits Adipogenesis Through the Extracellular Signal-Related Kinases-Peroxisome Proliferator-Activated Receptor-γ Pathway in Human Adipose Tissue-Derived Mesenchymal Stem Cells. Stem Cells Dev. 2011, 20(3):415-426.
20. Linhart H.G., Ishimura-Oka K., DeMayo F., Kibe T., Repka D., Poindexter B., et al. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(22):12532-12537.
21. Liu L.F., Shen W.J., Ueno M., Patel S., Kraemer F.B. Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. BMC Genomics 2011, 12(1):212.
22. Marigo I., Dazzi F. The immunomodulatory properties of mesenchymal stem cells. Semin. Immunopathol. 2011, 33:593-602.
23. McNeely S.C., Taylor B.F., States J.C. Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent. Toxicol. Appl. Pharmacol. 2008, 231(1):61-67.
24. Mougiakakos D., Jitschin R., Johansson C.C., Okita R., Kiessling R., Le Blanc K. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 2011, 117(18):4826-4835.
25. Nasr R., Guillemin M.C., Ferhi O., Soilihi H., Peres L., Berthier C., et al. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat. Med. 2008, 14(12):1333-1342.
26. Paul D.S., Harmon A.W., Devesa V., Thomas D.J., Styblo M. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ. Health Perspect. 2007, 115(5):734-742.
27. Pershagen G. The carcinogenicity of arsenic. Environ. Health Perspect. 1981, 40:93-100.
28. Raaijmakers M.H., Mukherjee S., Guo S., Zhang S., Kobayashi T., Schoonmaker J.A., et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010, 464(7290):852-857.
29. Rangwala S.M., Lazar M.A. Transcriptional control of adipogenesis. Annu. Rev. Nutr. 2000, 20:535-559.
30. Reinders M.E., Fibbe W.E., Rabelink T.J. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol. Dial. Transplant. 2010, 25(1):17-24.
31. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 1999, 4(4):611-617.
32. Rosen E.D., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache. J. Clin. Invest. 2000, 106(5):629-631.
33. Ruiz-Ramos R., Lopez-Carrillo L., Albores A., Hernandez-Ramirez R.U., Cebrian M.E. Sodium arsenite alters cell cycle and MTHFR, MT1/2, and c-Myc protein levels in MCF-7 cells. Toxicol. Appl. Pharmacol. 2009, 241(3):269-274.
34. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20(6):530-541.
35. Sekiya I., Larson B.L., Vuoristo J.T., Cui J.G., Prockop D.J. Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J. Bone Miner. Res. 2004, 19(2):256-264.
36. Sen A., Lea-Currie Y.R., Sujkowska D., Franklin D.M., Wilkison W.O., Halvorsen Y.D., et al. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J. Cell. Biochem. 2001, 81(2):312-319.
37. Siersbaek R., Nielsen R., Mandrup S. PPARgamma in adipocyte differentiation and metabolism-novel insights from genome-wide studies. FEBS Lett. 2010, 584(15):3242-3249.
38. Smith A.H., Hopenhayn-Rich C., Bates M.N. Cancer risks from arsenic in drinking water. Environ. Health Perspect. 1992, 97:259-267.
39. Song H., Cha M.J., Song B.W., Kim I.K., Chang W., Lim S., et al. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 2010, 28(3):555-563.
40. Strioga M.M., Viswanathan S., Darinskas A., Slaby O., Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 2012, (Epub ahead of print).
41. Sundin M., D'Arcy P., et al. Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity?. J. Immunother 2011, 34(4):336-342.
42. Takada I., Kouzmenko A.P., Kato S. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat. Rev. Rheumatol. 2009, 5(8):442-447.
43. Takada I., Kouzmenko A.P., Kato S. PPAR-gamma Signaling Crosstalk in Mesenchymal stem cells. PPAR Res. 2010, 2010:341671-341676.
44. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79(7):1147-1156.
45. Tontonoz P., Hu E., Devine J., Beale E.G., Spiegelman B.M. PPAR∼2 regulates adipose expression of the phospho-enolpyruvate carboxykinase gene. Mol. Cell. Biol. 1995, 15:351-357.
46. Trouba K.J., Wauson E.M., Vorce R.L. Sodium arsenite inhibits terminal differentiation of murine C3H 10T1/2 preadipocytes. Toxicol. Appl. Pharmacol. 2000, 168(1):25-35.
47. Urs S., Venkatesh D., Tang Y., Henderson T., Yang X., Friesel R.E., et al. Sprouty1 is a critical regulatory switch of mesenchymal stem cell lineage allocation. FASEB J. 2010, 24(9):3264-3273.
48. Van Den Berg D.J., Sharma A.K., Bruno E., Hoffman R. Role of members of the Wnt gene family in human hematopoiesis. Blood 1998, 92(9):3189-3202.
49. Walenda T., Bokermann G., Ventura Ferreira M.S., Piroth D.M., Hieronymus T., Neuss S., et al. Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Exp. Hematol. 2011, 39(6):617-628.
50. Wang L., Jin Q., Lee J.E., Su I.H., Ge K. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(16):7317-7322.
51. Wauson E.M., Langan A.S., Vorce R.L. Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis. Toxicol. Sci. 2002, 65(2):211-219.
52. Wu Z., Xie Y., Bucher N.L.R., Farmer S.R. Conditional ectopic expression of C/EBP[3 in NIH-3T3 cells induces PPAR∼ and stimulates adipogenesis. Genes Dev. 1995, 9:2350-2363.
53. Xue P., Hou Y., Zhang Q., Woods C.G., Yarborough K., Liu H., et al. Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: involvement of the adaptive antioxidant response. Biochem. Biophys. Res. Commun. 2011, 407(2):360-365.
54. Yadav S., Shi Y., Wang F., Wang H. Arsenite induces apoptosis in human mesenchymal stem cells by altering Bcl-2 family proteins and by activating intrinsic pathway. Toxicol. Appl. Pharmacol. 2010, 244(3):263-272.
55. Yeh W.-C., Cao Z., Classon M., McKnight S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 1995, 9:168-181.
56. Zhao R., Hou Y., Zhang Q., Woods C.G., Xue P., Fu J., Yarborough K., Guan D., Andersen M.E., Pi J. Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes. Environ. Health Perspect. 2012, 120(4):583-589.